Buy One Get One free -Llimited Time Offer X
Combitide 250 Octacap is a commercial drug that is prescribed in the form of Capsule. Secondary and off-label uses of Combitide 250 Octacap have also been mentioned below.
The optimal dosage of Combitide 250 Octacap is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
The most common side effects of Combitide 250 Octacap are Shortness of Breath, Throat Irritation, Nosebleed. Besides the aforementioned side effects, there are other adverse effects of Combitide 250 Octacap as well, which are listed below. Such side effects of Combitide 250 Octacap normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Combitide 250 Octacap's effect is Moderate during pregnancy and Mild for lactating mothers. It is important to know if Combitide 250 Octacap has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Combitide 250 Octacap related warnings section.
Other conditions have been mentioned below in the Combitide 250 Octacap contraindications section.
Additionally, Combitide 250 Octacap may also adversely react with other medicines. Refer to the list below for further details.
You should also be aware that Combitide 250 Octacap is safe while driving, and is addiction.
Combitide 250 Octacap is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Combitide 250 Octacap safe for pregnant women?
Combitide may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Combitide again without your doctor's advice.
Is the use of Combitide 250 Octacap safe during breastfeeding?
Breastfeeding women can take Combitide as it bears very minor side effects for them.
What is the effect of Combitide 250 Octacap on the Kidneys?
Combitide is not harmful for kidneys.
What is the effect of Combitide 250 Octacap on the Liver?
The liver can be affected by Combitide. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Combitide only after medical advice.
What is the effect of Combitide 250 Octacap on the Heart?
There may be an adverse effect on the heart after taking Combitide. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Combitide 250 Octacap unless your doctor advises you to do so -
Is this Combitide 250 Octacap habit forming or addictive?
No, there is no any evidence that Combitide 250 Octacap is addictive.
Interaction between Food and Combitide 250 Octacap
There is no information on the effects of taking Combitide 250 Octacap with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Combitide 250 Octacap
Information about the interaction of Combitide 250 Octacap and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359